Strata Oncology Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Strata Oncology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11114
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Strata Oncology Inc (Strata Oncology) is a precision oncology company. The company offers tumor sequencing to advanced cancer patients and a portfolio of biomarker-matched precision medicine trials. It identifies patients to design and conduct transformative precision oncology trials to accelerate the approval of breakthrough cancer medicines. Strata Oncology owns a cancer sequencing laboratory focused on testing gene targeted assays. The company works in partnership with Thermo Fisher Scientific Inc and other pharmaceutical companies. Strata Oncology is headquartered in Ann Arbor, Michigan, the US.

Strata Oncology Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Strata Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Strata Oncology Inc, Medical Devices Deals, 2012 to YTD 2018 9
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Strata Oncology Raises USD26 Million in Series B Venture Financing 11
Strata Oncology Raises USD12 Million in Series A Venture Financing 13
Partnerships 14
Puma Biotechnology and Strata Oncology Enter into Collaboration Agreement 14
Strata Oncology Enters into Agreement with University of California 15
Strata Oncology Enters into Agreement with EpiZymev 16
Clovis Oncology Enters into Agreement with Strata Oncology 17
Strata Oncology Inc – Key Competitors 18
Strata Oncology Inc – Key Employees 19
Strata Oncology Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Nov 08, 2018: Strata Oncology names Scott A. Tomlins, M.D., Ph.D., Chief Medical Officer 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Strata Oncology Inc, Pharmaceuticals & Healthcare, Key Facts 2
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Strata Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Strata Oncology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Strata Oncology Inc, Medical Devices Deals, 2012 to YTD 2018 9
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Strata Oncology Raises USD26 Million in Series B Venture Financing 11
Strata Oncology Raises USD12 Million in Series A Venture Financing 13
Puma Biotechnology and Strata Oncology Enter into Collaboration Agreement 14
Strata Oncology Enters into Agreement with University of California 15
Strata Oncology Enters into Agreement with EpiZymev 16
Clovis Oncology Enters into Agreement with Strata Oncology 17
Strata Oncology Inc, Key Competitors 18
Strata Oncology Inc, Key Employees 19

List of Figures
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Strata Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Strata Oncology Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Strata Oncology Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medherant Ltd:企業の製品パイプライン分析2018
    Summary Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormo …
  • Western Farmers Electric Cooperative:企業の発電所・SWOT分析2018
    Western Farmers Electric Cooperative - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Volkswind GmbH-エネルギー分野:企業M&A・提携分析
    Summary Volkswind GmbH (Volkswind), a subsidiary of Axpo Holding AG, is an independent renewable power producer. It undertakes the planning, development, construction and operations of wind power plants. Volkswind builds wind farms with wind turbines from various suppliers including Seimens, Enercon …
  • Paychex, Inc.:企業の戦略・SWOT・財務分析
    Paychex, Inc. - Strategy, SWOT and Corporate Finance Report Summary Paychex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Avacta Group Plc (AVCT):企業の製品パイプライン分析2018
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an …
  • Giesecke & Devrient GmbH:企業の戦略・SWOT・財務分析
    Giesecke & Devrient GmbH - Strategy, SWOT and Corporate Finance Report Summary Giesecke & Devrient GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Korea Research Institute of Chemical Technology:製薬・医療:M&Aディール及び事業提携情報
    Summary Korea Research Institute of Chemical Technology (KRICT) is a chemical institute that develops chemical process technologies. The institute provides green technology, chemical materials, drug candidates, and chemistry based fusion technologies. Its green chemistry research includes petroleum …
  • Petroleo Brasileiro SA (PETR4):電力:M&Aディール及び事業提携情報
    Summary Petroleo Brasileiro SA (Petrobras) is an integrated oil and gas company. Its major businesses include exploration and production, refining, marketing, trade and transportation of oil and gas. The company also conducts biofuel, petrochemical, natural gas, electricity and chemical businesses, …
  • Cavco Industries Inc:企業の戦略・SWOT・財務情報
    Cavco Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Cavco Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Credit Suisse (UK) Private Banking:企業の戦略・SWOT・財務情報
    Credit Suisse (UK) Private Banking - Strategy, SWOT and Corporate Finance Report Summary Credit Suisse (UK) Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Gore Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Gore Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Gore Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • EnGeneIC Ltd-製薬・医療分野:企業M&A・提携分析
    Summary EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference m …
  • Stockland Corporation Ltd:企業のM&A・事業提携・投資動向
    Stockland Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stockland Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • JCDecaux SA:企業の戦略・SWOT・財務分析
    JCDecaux SA - Strategy, SWOT and Corporate Finance Report Summary JCDecaux SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Idera Pharmaceuticals Inc (IDRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Idera Pharmaceuticals Inc. (Idera) is a clinical stage biopharmaceutical company, which focuses on the discovery, development and commercialization of drugs for the treatment of cancer and rare diseases. It develops DNA and RNA based drug candidates aimed at toll-like receptors (TLR) for the …
  • Cleveland HeartLab Inc-医療機器分野:企業M&A・提携分析
    Summary Cleveland HeartLab Inc (Cleveland HeartLab) is a clinical laboratory that provides cardiovascular testing services. The company offers services such as cardiovascular risk assessment, novel diagnostic tests, inflammatory and other advanced biomarker testing, management and prevention of hear …
  • HTP Korcula d.d.:企業の戦略・SWOT・財務分析
    HTP Korcula d.d. - Strategy, SWOT and Corporate Finance Report Summary HTP Korcula d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Endesa SA:企業の発電所・SWOT分析2018
    Endesa SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • O’Reilly Automotive, Inc. (ORLY):企業の財務・戦略的SWOT分析
    Summary O'Reilly Automotive Inc (O’Reilly) is a provider of automotive parts. The company offers automotive parts, tools, equipment, supplies and accessories. The company offers various services such as battery diagnostic testing; battery, wiper and bulb replacement; check and engine light code extr …
  • Merit Medical Systems Inc (MMSI):企業の財務・戦略的SWOT分析
    Merit Medical Systems Inc (MMSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆